NHS England
NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza
May 15, 2019Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy
NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …
NHS England threatened legal action against Oxford University hospitals trust
April 4, 2019Medical Communications, Research and Development Hopsitals, NHS, NHS England, OUH, cancer screening, patients
NHS England threatened to sue Oxford University hospitals (OUH) NHS trust after they objected to the former’s controversial decision to …
NHS chief warns of rise of anti-vaccine ‘fake news’ online
March 4, 2019Sales and Marketing NHS, NHS England, Simon Stevens, anti vaxxer, fake news, vaccines
The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’. …
Data reveals November’s performance was worst on record for NHS
December 14, 2018Medical Communications NHS, NHS England, UK, funding, investment, wait times
November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …
NHS England seals access deals with big pharma for breast cancer and MS
November 9, 2017Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis
NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …
UK High Court rejects ABPI’s challenge to new NICE cost curbs
October 5, 2017Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical
The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …
HIV-preventing drug to be trialed across England
August 7, 2017Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical
NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …
NHS England takes tough stance on homeopathy
July 24, 2017Sales and Marketing NHS England, biotech, drugs, pharma, pharmaceutical
Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by …
ABPI launches legal action to overturn £20m price cap
July 11, 2017Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE
When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …
Number of patients at risk from NHS mail mistake revealed
June 27, 2017Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England
According to the patient records that have been examined so far, at least 1,700 may have been put at risk …
Cuts to prescriptions aims to save £128 million annually
March 28, 2017Medical Communications, Research and Development NHS England, prescription
NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …
NICE drug expense limit of £20 million could cause treatment delays
March 16, 2017Medical Communications, Sales and Marketing NHS England, NICE, fast-track appraisal process, rare disease
NICE has released its decision on the fast-track approval process and other changes that will be brought through at the …
Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court
A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …
ABPI welcomes recommendations from NHS specialised services report
April 27, 2016Research and Development, Sales and Marketing ABPI, NHS, NHS England, NICE, National Audit Office, report, specialised services
The ABPI has welcomed the findings of a National Audit Office report on the commission of specialised service by NHS …
NHS England approves Cancer Drugs Fund proposals
February 26, 2016Medical Communications, Research and Development ABPI, Cancer Drugs Fund, NHS England
NHS England has approved proposed reforms of the Cancer Drugs Fund, following the end of the 12-week consultation period earlier …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
